Evidence map›Paper›PMID 27388464›Full record

ReviewEuropean journal of nutrition2017

Fruitflow

Niamh O'Kennedy, Daniel Raederstorff, Asim K Duttaroy

Registry-linked trialAbstract readReview
In one paragraph

Review in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03206944 (Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects at High Estimated Cardiovascular Risk), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03206944 phase4completednot on this map

Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects at High Estimated Cardiovascular Risk

TypeinterventionalSponsorBeata KrasinskaRan2015 to 2017Enrolled82ConditionsHypertension,Essential, ObesityArmsacetylsalicylic acid, Tomato Fruit Extract
3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Investigation of Platelet Aggregation in Atherosclerosis.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Niamh O'KennedyProvexis PLC, Reading, UK.
Daniel RaederstorffDSM Nutritional Products Ltd, 4002, Basel, Switzerland.
Asim K DuttaroyDepartment of Nutrition, Institute for Basic Medical Sciences, Faculty of Medicine, University of Oslo, POB 1046, Blindern, 0316, Oslo, Norway. a.k.duttaroy@medisin.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperactive platelets, in addition to their roles in thrombosis, are also important mediators of atherogenesis. Antiplatelet drugs are not suitable for use where risk of a cardiovascular event is relatively low. It is therefore important to find alternative safe antiplatelet inhibitors for the vulnerable population who has hyperactive platelets in order to reduce the risk of cardiovascular disease. Potent antiplatelet factors were identified in water-soluble tomato extract (Fruitflow

Indexed as

Food SafetyFunctional FoodPlatelet Aggregation InhibitorsAngiotensin-Converting Enzyme InhibitorsAnti-Inflammatory AgentsAtherosclerosisBlood PlateletsCardiotonic AgentsCardiovascular DiseasesEuropeHumansPlant ExtractsPlatelet AggregationSolanum lycopersicumAngiotensin-Converting Enzyme InhibitorsAnti-Inflammatory AgentsCardiotonic AgentsPlant ExtractsPlatelet Aggregation InhibitorsADPAngiotensin-converting enzymeBlood pressureEFSA health claimEU regulation 1924/2006Fruitflow®Human plateletsPlatelet activationPolyphenolsTomatoWater-soluble tomato extract

Identifiers

PMID27388464
PMCPMC5334395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.